Topic Archives: ViewRay (VRAY)

Andrew Snyder has been on the editorial team of a bunch of different Agora-affiliated newsletters over the years, and is now helming his own little offshoot called Manward Press — a publishing imprint that aims to help men reach “true fulfillment” by focusing on “Liberty, Know-how and connections” … though, of course, to sell newsletters […]

Lots and lots and lots of you have been asking me about the big “cancer presentation” that the Stansberry folks made last night, which apparently was a combination of Dr. David Eifrig’s medical advice and forecasting and Dave Lashmet’s hinting about his “medical breakthrough” stock… so let’s get to it. I did not watch or […]

Comments

  • Apart from drug therapy, it might be profitable to look into a new technique in radiation treatments - two players Elekt...

  • Oh, and yes, it turns out that long Elekta/short ViewRay would have been the right call -- VRAY is down 23% at the momen...

  • I joined the same webinar and took careful notes. It was mentioned that the stock in question was in an uptrend. So, I a...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info